PBM/Manufacturer Therapeutic Substitution Contracts Sought In FTC Study

The Federal Trade Commission is asking pharmacy benefit management companies to submit their "therapeutic substitution" contracts with pharmaceutical manufacturers as part of a study of "conflicts of interest" in the PBM sector